secwatch / observer
8-K filed April 21, 2026, 7:59 PM ET ticker CELU CIK 0001752828
other material confidence high sentiment negative materiality 0.75

Celularity Inc (CELU): debt financing — Celularity closes $13.3M NexGel asset sale; Helena default notice on $1.97M note

Celularity Inc

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Celularity Inc reported a default on convertible notes with Helena Global Investment Opportunities 1 Ltd. at 15% per annum.

Instrument
convertible notes
Counterparty
Helena Global Investment Opportunities 1 Ltd.
Rate
15% per annum
Event
default
Exact text from the filing
On April 17, 2026, Helena delivered to the Company a notice of event of default (the “Default Notice”) under the Helena Note.
View on SEC.gov
Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Celularity Inc incurred convertible notes of $1,970,502.58 with Helena Global Investment Opportunities 1 Ltd. at 18.0% per annum maturing October 16, 2026.

Instrument
convertible notes
Principal
$1,970,502.58
Counterparty
Helena Global Investment Opportunities 1 Ltd.
Rate
18.0% per annum
Maturity
October 16, 2026
Event
incurrence
Exact text from the filing
for a Convertible Promissory Note in the original principal amount of $1,970,502.58 (the “Helena Note”). The Helena Note bears interest at a rate of 18.0% per annum and matures on October 16, 2026
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Celularity Inc amended Amendment No. 1 with NexGel, Inc. valued at $13.3 million (effective 2026-04-17).

Action
amendment
Agreement
asset purchase
Counterparty
NexGel, Inc.
Value
$13.3 million
Effective
2026-04-17
Exact text from the filing
On April 17, 2026, Celularity Inc. (the “Company”) entered into Amendment No. 1 (the “Amendment”) to that certain Asset Purchase and Exclusive License Agreement, dated as of March 6, 2026 (the “Original Agreement” and, as amended, the “Agreement”), with NexGel, Inc. (“NexGel”). Among other things, the Amendment provides that: (i) the aggregate consideration payable to the Company under the Agreement is $13.3 million, consisting of an upfront cash payment of $8.3 million on the transaction commencement date and a convertible promissory note in the original principal amount of $5.0 million with an 18-month term
View on SEC.gov

114 debt financings filed in the last 30 days. Browse all debt financings →

Celularity Inc filing history →

Source: SEC EDGAR
accession 0001493152-26-018220
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.